An interventional study of Cognitive Behavioral Therapy- Based and Motivational Interviewing-Supported Psychoeducation in Obesity, sponsored by Inonu University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-04.
Sponsored by Inonu University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 353 studies in Obesity with a site in Turkey — 73 open to participants now, 90 under way, 16 of them phase 3. Obesity · Turkey.
Among the 353 studies in Obesity with a site in Turkey, this one is the 68th largest by enrollment of the 192 interventional ones that give a count, is one of 38 that started in 2024, is one of 161 with no phase, and was the 185th registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →73 of the 353 studies in Obesity with a site in Turkey are open now. Recruiting first, the newest first:
Pamukkale University · Sites in Turkey
Ages 18–65 · Women only
Gazi University · Sites in Turkey
Ages 50–60 · Women only
Duzce University · Sites in Turkey
Ages 18+
Pamukkale University · Sites in Turkey
Ages 18–60 · Women only
Kocaeli University · Sites in Turkey
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
353 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 27 · Phase 4 3
First in 2005; this study’s year is marked. 38 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 84 is above the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 64 across the 192 interventional studies, 82 across the 160 observational. Of the 237 that completed or were terminated, 7 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
34 of 353 have an industry lead sponsor. The 10 most frequent:
Inonu University is the lead sponsor of 399 studies on the registry; 98 are open to participants now.
Inonu University has 5 studies filed under Obesity — fewer than ten, so there is no comparison to draw.
33 of the studies in Obesity with a site in Turkey that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05556512Phase 3Eli Lilly and CompanyA Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity | 2027-10 |
| NCT07769736Istinye UniversityMotivational Interviews Based on the Five-Step (5A) Model on Obesity Risk | 2026-11 |
| NCT07652151Fundación Pública Andaluza para la gestión de la Investigación en SevillaUNMASK: Unveiling the Pathobiology of Metabolic Dysfunction-Associated Steatotic Liver Disease for the Discovery of Novel Therapeutics and Biomarkers | 2026-11 |
| NCT07846956Istanbul Saglik Bilimleri UniversityNAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World Study | 2026-11-30 |
| NCT07858864Istanbul Saglik Bilimleri UniversityGLP-1 Receptor Agonist Use and Sarcopenia in Obese Individuals Without Diabetes | 2026-11-30 |
Add all 33 to your calendar (.ics) → With an account.
Among the 353 studies in Obesity with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this study was to examine the effects of cognitive-behavioral and motivational interviewing-supported psychoeducation on emotional eating and psychological resilience in individuals with obesity. The study was conducted using a randomized controlled experimental design. The initial planned sample size was 102 individuals, with 51 participants allocated to each group. However, due to difficulties in participant recruitment, a subsequent power analysis was conducted, which indicated a minimum total sample size of 32 participants. Ultimately, 84 individuals who met the inclusion criteria were randomized into the experimental (n = 42) and control (n = 42) groups, and 81 participants completed the study (experimental: n = 40; control: n = 41). A cognitive-behavioral and motivational interviewing-supported psychoeducation program was applied to the experimental group. Participants were evaluated at three time points: pre-test (baseline), post-test (8 weeks), and follow-up test (2 months after the post-test). No intervention was applied to the control group. The Emotional Eating Scale and Psychological Resilience Scale were used as data collection tools in the study. The study tested the hypothesis that the cognitive-behavioral and motivational interviewing-supported psychoeducation program would be effective in reducing emotional eating levels and increasing psychological resilience in individuals with obesity. The findings of the study may contribute to understanding the potential importance of psychological approaches in the treatment of obesity.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Obese individuals in this group receive the structured cognitive behavioral therapy-based and motivational interviewing-supported psychoeducation program.
Behavioral: Cognitive Behavioral Therapy- Based and Motivational Interviewing-Supported Psychoeducation
Obese individuals in this group did not receive any interventional procedure during the study period. Only assessment measurements were conducted for research purposes. After completion of follow-up assessments, the psychoeducation program was offered to those who requested it.
An 8-week structured psychoeducation program based on cognitive behavioral therapy principles and supported by motivational interviewing techniques.
Emotional Eating Scale
Emotional eating was assessed using the Emotional Eating Scale (EES). Scores range from 0 to 30; higher scores indicate a worse outcome (greater emotional eating).
Time frame: Baseline; end of week 8 (post-intervention); 2-month follow-up
Resilience scale
Resilience was assessed using a resilience scale. Scores range from 0 to 84; higher scores indicate greater resilience (better outcome).
Time frame: Baseline; post-intervention (end of week 8); 2-month follow-up
Ran from Nov 2024 to primary completion in Aug 2025, 8 months.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 8 months is below that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
Primary completion moved once since we started tracking on Sep 25, 2026: Jun 2025 → Aug 2025, on Nov 4, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.